Publication | Open Access

A genital tract peptide epitope vaccine targeting TLR-2 efficiently induces local and systemic CD8+ T cells and protects against herpes simplex virus type 2 challenge

VaccinationAdaptive Immune SystemVaccine TargetImmunologyEpitope VaccineImmunodominanceGenital TractTherapeutic VaccineAutoimmunityT Cell ImmunityVaccine DesignImmunotherapyMedicineImmunological Memory